Bullish option flow detected in Aclaris Therapeutics with 3,127 calls trading, 1.9x expected, and implied vol increasing almost 29 points to 467.04%. Nov-23 12 calls and Dec-23 12.5 calls are the most active options, with total volume in those strikes near 1,400 contracts. The Put/Call Ratio is 0.23. Earnings are expected on February 22nd.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ACRS:
- Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
- Aclaris Therapeutics reports Q3 EPS (41c), consensus (48c)
- ACRS Upcoming Earnings Report: What to Expect?
- Cantor biotech/biopharma analysts to hold an analyst/industry conference call
- Aclaris Therapeutics initiated with an Outperform at Evercore ISI
